181 related articles for article (PubMed ID: 22875025)
21. An autologous tumor vaccine for CLL.
Zhu F; Khatri I; Spaner D; Gorczynski RM
Leuk Res; 2018 May; 68():40-47. PubMed ID: 29525600
[TBL] [Abstract][Full Text] [Related]
22. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
[TBL] [Abstract][Full Text] [Related]
23. Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.
D'Auria F; Guariglia R; Villani O; Mansueto G; Grieco V; Zonno A; Bianchino G; Di Giovannantonio L; Vita G; Musto P
Clin Ther; 2010 Oct; 32(11):1911-6. PubMed ID: 21095486
[TBL] [Abstract][Full Text] [Related]
24. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.
McWhirter JR; Kretz-Rommel A; Saven A; Maruyama T; Potter KN; Mockridge CI; Ravey EP; Qin F; Bowdish KS
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1041-6. PubMed ID: 16418292
[TBL] [Abstract][Full Text] [Related]
25. CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia.
D'Arena G; Vitale C; Coscia M; Lamorte D; Pietrantuono G; Perutelli F; D'Auria F; Statuto T; Valvano L; Tomasso A; Griggio V; Jones R; Mansueto G; Villani O; D'Agostino S; Viglioglia V; De Feo V; Calapai F; Mannucci C; Sgambato A; Efremov DG; Laurenti L
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439393
[TBL] [Abstract][Full Text] [Related]
26. Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression.
Twito T; Chen Z; Khatri I; Wong K; Spaner D; Gorczynski R
Leuk Res; 2013 Jul; 37(7):816-21. PubMed ID: 23643150
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
28. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.
Flavell DJ; Warnes SL; Noss AL; Flavell SU
Br J Cancer; 2000 Dec; 83(12):1755-61. PubMed ID: 11104577
[TBL] [Abstract][Full Text] [Related]
30. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice.
Di Ianni M; Terenzi A; Falzetti F; Bartoli A; Di Florio S; Benedetti R; Venditti G; Alfonsi D; De Ioanni M; Falini B; Tabilio A
Cancer Gene Ther; 2002 Sep; 9(9):756-61. PubMed ID: 12189525
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
Mohammad RM; Mohamed AN; Hamdan MY; Vo T; Chen B; Katato K; Abubakr YA; Dugan MC; al-Katib A
Leukemia; 1996 Jan; 10(1):130-7. PubMed ID: 8558918
[TBL] [Abstract][Full Text] [Related]
32. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
33. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
[TBL] [Abstract][Full Text] [Related]
35. Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.
Mahadevan D; Lanasa MC; Farber C; Pandey M; Whelden M; Faas SJ; Ulery T; Kukreja A; Li L; Bedrosian CL; Zhang X; Heffner LT
J Immunother Cancer; 2019 Aug; 7(1):227. PubMed ID: 31443741
[TBL] [Abstract][Full Text] [Related]
36. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.
Bagnara D; Kaufman MS; Calissano C; Marsilio S; Patten PE; Simone R; Chum P; Yan XJ; Allen SL; Kolitz JE; Baskar S; Rader C; Mellstedt H; Rabbani H; Lee A; Gregersen PK; Rai KR; Chiorazzi N
Blood; 2011 May; 117(20):5463-72. PubMed ID: 21385850
[TBL] [Abstract][Full Text] [Related]
37. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Litchy S; Barton JH; Houston GA; Hermann RC; Bradof JE; Greco FA;
J Clin Oncol; 2003 May; 21(9):1746-51. PubMed ID: 12721250
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγ(null) mice generates humanized mice that improve functional B cell development.
Chung YS; Son JK; Choi B; Park JB; Chang J; Kim SJ
Clin Immunol; 2015 Dec; 161(2):308-15. PubMed ID: 26360254
[TBL] [Abstract][Full Text] [Related]
39. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
